Department of Ophthalmology, Vagelos College of Physicians and Surgeons.
Edward S. Harkness Eye Institute, Columbia University Irving Medical Center.
J Glaucoma. 2021 May 1;30(5):388-394. doi: 10.1097/IJG.0000000000001795.
The Manhattan Vision Screening and Follow-up Study in Vulnerable Populations is a 5-year prospective, cluster-randomized study to improve detection and management of glaucoma and other eye diseases in vulnerable populations living in affordable housing developments.
To describe the study design and methodology of the Manhattan Vision Screening and Follow-up Study in Vulnerable Populations, which aims to investigate whether community-based vision screenings can improve detection and management of glaucoma, vision impairment, cataract, and other eye diseases among vulnerable populations living in affordable housing developments in upper Manhattan.
This 5-year prospective, cluster-randomized, controlled trial consists of vision screening and referral for follow-up eye care among eligible residents aged 40 and older. Visual acuity, intraocular pressure (IOP), and fundus photography are measured. Participants with visual worse than 20/40, or IOP 23 to 29 mm Hg, or unreadable fundus images fail the screening and are scheduled with the on-site optometrist. Those with an abnormal image and/or IOP ≥30 mm Hg, are assigned as "fast-track" and referred to ophthalmology. Participants living in 7 developments randomized to the Enhanced Intervention Group who fail the screening and need vision correction receive complimentary eyeglasses. Those referred to ophthalmology receive enhanced support with patient navigators to assist with follow-up eye care. Participants living in 3 developments randomized to the Usual Care Group who fail the screening and need vision correction are given an eyeglasses prescription only and a list of optical shops. No enhanced support is given to the Usual Care Group. All participants referred to ophthalmology are assisted in making their initial eye exam appointment.
This study targets vulnerable populations where they live to ensure improved access to and utilization of eye care services in those who are least likely to seek eye care.
曼哈顿弱势群体视觉筛查和随访研究是一项为期 5 年的前瞻性、集群随机研究，旨在改善弱势群体在经济适用房开发中对青光眼和其他眼部疾病的检测和管理。
描述曼哈顿弱势群体视觉筛查和随访研究的研究设计和方法，该研究旨在调查社区为基础的视力筛查是否可以提高在上曼哈顿经济适用房开发中生活的弱势群体对青光眼、视力障碍、白内障和其他眼部疾病的检测和管理。
这是一项为期 5 年的前瞻性、集群随机、对照试验，包括对 40 岁及以上合格居民进行视力筛查和后续眼科护理转诊。测量视力、眼压（IOP）和眼底摄影。视力低于 20/40 或 IOP 23 至 29mmHg 或眼底图像不可读的患者筛查失败，并安排现场验光师就诊。那些图像异常和/或 IOP≥30mmHg 的患者被归为“快速通道”并转诊至眼科。在增强干预组中，居住在 7 个随机开发项目中且筛查失败需要视力矫正的参与者将获得免费眼镜。转诊至眼科的患者将获得患者导航员的增强支持，以帮助他们进行后续眼科护理。居住在 3 个随机分组为常规护理组且筛查失败需要视力矫正的参与者仅获得配镜处方和光学商店清单。常规护理组不提供增强支持。所有转诊至眼科的患者都将获得协助进行初始眼科检查预约。
该研究针对的是弱势群体居住的地方，以确保那些最不可能寻求眼科护理的人能够更好地获得和利用眼科护理服务。
